FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

GENEREX BIOTECHNOLOGY CORP: cashflow_financing

One fact, its scope and the complete path back to the official record.

Period: 2018-08-01 – 2018-10-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/3738947b-0576-41d1-831c-feffd94b2842

Reported value

$625.967k{"amount": 625967, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Entity
GENEREX BIOTECHNOLOGY CORP
Metric
cashflow_financing
Period
2018-08-01 – 2018-10-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001607062-18-000486 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T10:26:37.356960+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001059784/cashflow-financing/2018-10-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.